Squarepoint
DVAX

Squarepoint’s Dynavax Technologies DVAX Stock Holding History

Squarepoint’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50,200
Closed -$651K – 4616
2025
Q1 		$651K Buy
+50,200
New +$664K ﹤0.01% 3049

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Squarepoint's DVAX Position: Q1 2026 in Review

Squarepoint sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 31,416 shares — an estimated $483K sold.

Squarepoint first reported a position in DVAX in Q4 2015 and held it in 25 quarters. The position peaked at $4.32M in Q2 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Squarepoint reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 31,416 Dynavax Technologies shares in Q1 2026, an estimated $483K.
  • Squarepoint first reported a position in Dynavax Technologies in Q4 2015 and held it in 25 quarters.
  • Squarepoint's Dynavax Technologies position peaked at $4.32M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.